Most Read Articles
Pearl Toh, 6 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 2 days ago
Treatment with hydroxychloroquine appears to significantly reduce viral load in patients with the novel coronavirus disease (COVID-19), with its beneficial effects reinforced by adding azithromycin, results of a recent study have shown.
Dr. Joseph Delano Fule Robles, 04 Sep 2017

A recent genome-wide association study (GWAS) performed by investigators from the Chinese University of Hong Kong (CUHK) has found potential new indications for existing drugs for the treatment of various psychiatric disorders. 

Audrey Abella, 6 days ago
The angiotensin receptor blocker (ARB) losartan did not improve inflammation, T-cell immune recovery, or fibrotic activity among older persons living with HIV (PLHIV) and viral suppression, according to data presented at CROI 2020.

COVID-19: Virus found in aerosols, on surfaces for hours to days post-exposure

Rachel Soon
Medical Writer
14 Mar 2020
(Photo credit: CDC/Unsplash)

SARS-CoV-2 may remain in aerosols over 3 hours after exposure, and on surfaces up to 3 days, making it similar to SARS-CoV-1 in environmental stability, according to a new study.

An investigation by a team under the US National Institute of Allergy and Infectious Diseases (NIAID) found that viable SARS-CoV-2 particles could be detected in aerosols up to 3 hours post-aerosolization, and up to 4 hours on copper, up to 24 hours on cardboard, and up to 2-3 days on plastic and stainless steel surfaces after exposure. [medRxiv 2020; doi:10.1101/2020.03.09.20033217]

“Our results indicate that aerosol and fomite transmission of HCoV-19* is plausible,” said the researchers.

However, study leader Neeltje van Doremalen was careful to stress that the study—currently in preprint and pending peer review—did not prove anyone had been infected by breathing aerosolized particles or touching contaminated surfaces.

“Important: we experimentally generated aerosols and kept them afloat in a drum. This is not evidence of aerosol transmission,” said van Doremalen in a Twitter post on 11 March. [https://twitter.com/DrNeeltje/status/1237743987890343938]

The study compared one strain of SARS-CoV-2 and one of SARS-CoV-1 at similar infectious titres under controlled laboratory conditions that were significant to healthcare settings. Aerosols were tested as they are produced by certain medical procedures, while the four surface types were those commonly found in hospitals.

To test viral viability in aerosols, the researchers nebulized both strains and maintained them using a Goldberg drum (21–23°C, relative humidity 65 percent), from which samples were collected by gelatin filters after 0, 30, 60, 120, and 180 minutes.

They detected viable SARS-CoV-2 particles in aerosol up to the 180-minute mark, though concentration was reduced (infectious titre 103.5 to 102.7 TCID50/mL**). A similar reduction was observed in the SARS-CoV-1 strain (104.3 to 103.5 TCID50/mL).

For surface viability, 50 μl of 105 TCID50/mL of both strains were applied to polypropylene, cardboard, stainless steel, and copper surfaces, with samples taken after 1, 4, 8, 24, 48, 72, and 96 hours (21–23°C, relative humidity 40 percent).

On polypropylene, both viruses were detectable up to 72 hours, though with greatly reduced virus titre (SARS-CoV-2, 103.7 to 100.6 TCID50/mL; SARS-CoV-1, 103.4 to 100.7 TCID50/mL). On stainless steel, similar kinetics were observed in both, though the virus was only detectable up to 48 hours (SARS-CoV-2, 103.7 to 100.6 TCID50/mL; SARS-CoV-1, 103.6 to 100.6 TCID50/mL).

No viable virus was detectable after 4 hours on copper for SARS-CoV-2 and 8 hours for SARS-CoV-1, and after 24 hours on cardboard for SARS-CoV-2 and 8 hours for SARS-CoV-1.

At the 96-hour mark, no detectable levels of virus were found on any of the four surfaces.

All viability tests were repeated three times, with results reflecting the mean data. Decay rates were estimated using a Bayesian regression model.

In their discussion, the researchers noted that given how similar the environmental viabilities of the two viruses were, the greater transmissibility of SARS-CoV-2 was likely due to other factors such as pre-symptomatic or asymptomatic viral shedding, the infectious dose needed to establish infections, and variations in temperature and humidity.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 6 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 2 days ago
Treatment with hydroxychloroquine appears to significantly reduce viral load in patients with the novel coronavirus disease (COVID-19), with its beneficial effects reinforced by adding azithromycin, results of a recent study have shown.
Dr. Joseph Delano Fule Robles, 04 Sep 2017

A recent genome-wide association study (GWAS) performed by investigators from the Chinese University of Hong Kong (CUHK) has found potential new indications for existing drugs for the treatment of various psychiatric disorders. 

Audrey Abella, 6 days ago
The angiotensin receptor blocker (ARB) losartan did not improve inflammation, T-cell immune recovery, or fibrotic activity among older persons living with HIV (PLHIV) and viral suppression, according to data presented at CROI 2020.